Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Flares
Public ClinicalTrials.gov record NCT07645820. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Evaluation of a Non-Invasive Device for Early Detection of Flares in Adults and Adolescents With Atopic Dermatitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will collect skin measurements from people with atopic dermatitis (AD) using the investigational Nevisense Go device. Participants aged 12 to 89 years with a history of AD flares will use the device at home for about 90 days. Participants will complete device measurements, electronic diary entries, and up to five in-person study visits. The study is based on the idea that changes in skin barrier function may occur before an AD flare becomes visible or symptoms begin. Information collected during the study, including device measurements, diary entries, and investigator assessments, will be used to evaluate whether these changes may help estimate the likelihood of an AD flare before visible signs or symptoms occur.
Study identification
- NCT ID
- NCT07645820
- Recruitment status
- Recruiting
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 450 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years to 89 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 4, 2026 (Actual)
- Primary completion
- Apr 1, 2027 (Estimated)
- Completion
- Dec 31, 2027 (Estimated)
- Last update posted
- Oct 20, 2026
2026 – 2027
United States locations
- U.S. sites
- 13
- U.S. states
- 11
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| U.S. Dermatology Partners | Phoenix | Arizona | 85006 | Recruiting |
| James Y. Wang MD, Inc | Los Angeles | California | 90017 | Recruiting |
| U.S. Dermatology Partners Rockville | Rockville | Maryland | 20850 | Recruiting |
| Derm Research Institute, PLC | Caledonia | Michigan | 49316 | Recruiting |
| U.S. Dermatology Partners Lee's Summit | Lee's Summit | Missouri | 64064 | Recruiting |
| Advanced Dermatology and Cosmetic Surgery - Henderson | Henderson | Nevada | 89052 | Recruiting |
| Las Vegas Dermatology | Las Vegas | Nevada | 89144 | Recruiting |
| StracSkin, PLLC | Portsmouth | New Hampshire | 03801 | Recruiting |
| DCOL Center for Clinical Research | Longview | Texas | 75605 | Recruiting |
| Harrison Dermatology | Missouri City | Texas | 77459 | Recruiting |
| Jordan Valley Dermatology | South Jordan | Utah | 84095 | Recruiting |
| Virginia Clinical Research, Inc | Norfolk | Virginia | 23502 | Recruiting |
| West Virginia Research Institute | Morgantown | West Virginia | 26505 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07645820, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 20, 2026 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07645820 live on ClinicalTrials.gov.